Gilead Sciences, Inc. 13D and 13G filings for Leap Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-04-19 4:31 pm Purchase |
2024-04-10 | 13G | Leap Therapeutics, Inc. LPTX |
GILEAD SCIENCES INC GILD |
5,319,148 13.900% |
5,319,148 (New Position) |
Filing |